Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Polymyalgia rheumatica - Management
What else might it be?

  • It is important to rule out conditions that can present with features similar to those of polymyalgia rheumatica, particularly conditions where use of systemic corticosteroids could have harmful consequences.
  • The process of ruling out other possible conditions is lengthy, because diseases such as rheumatoid arthritis can take many months to become apparent, especially if treatment with corticosteroids is started. The initial diagnosis of polymyalgia rheumatica is thus, in effect, a 'working diagnosis'.
  • Features that indicate increased likelihood of the diagnosis being a condition other than polymyalgia rheumatica include:
    • Onset at less than 65 years of age.
    • Incomplete response to treatment with corticosteroids.
    • Weakness — suggests polymyositis.
    • Prominent peripheral joint symptoms — suggest rheumatoid arthritis or remitting seronegative symmetrical synovitis with pitting oedema syndrome.
    • Presence of other atypical clinical features (for example lack of shoulder pain, no muscle stiffness, and unilateral rather than bilateral girdle pain).
  • See Table 1 for examples of disorders that can cause similar symptoms.
Table 1. Examples of disorders that can cause similar symptoms to polymyalgia rheumatica.
Differential diagnosis
Examples
Degenerative disorders (may coexist with polymyalgia rheumatica and increase the need for steroid therapy)
Cervical and lumbar spondylosis
Osteoarthritis
Bilateral adhesive capsulitis (frozen shoulder), rotator cuff disorders
Osteoporosis
Endocrine disorders
Thyroid disease
Parathyroid disease
Infection
Chronic osteomyelitis
Viral illness
Tuberculosis
Infective endocarditis
Inflammatory disorders
Rheumatoid arthritis, often seronegative for rheumatoid factor (common)
Spondyloarthropathy (rare)
Remitting seronegative symmetric synovitis with pitting oedema (rare)
Polymyositis/dermatomyositis
Systemic lupus erythematosus
Other connective tissue disorders
Muscle disorders
Proximal myopathy (for example, corticosteroid-induced)
Muscular dystrophy
Malignancy
Multiple myeloma
Leukaemia
Lymphoma
Lung carcinoma
Other occult carcinomas
Neurological disorders
Parkinson's disease
Myasthenic syndromes
Psychiatric disorders
Depression
Drug adverse effects
Myositis or myalgia due to statins
Polymylagia rheumatica-like syndrome due to quinidine
Miscellaneous
Osteomalacia
Fibromyalgia
Chronic fatigue syndrome
Chronic pain syndromes

© NHS Institute for Innovation and Improvement